Your browser doesn't support javascript.
loading
Infliximab vs adalimumab for Crohn's disease.
Dhillon, Angad S; Harris, Adam W.
Affiliation
  • Dhillon AS; Department of Gastroenterology, Tunbridge Wells Hospital, Kent, United Kingdom.
  • Harris AW; Department of Gastroenterology, Tunbridge Wells Hospital, Kent, United Kingdom.
Clin Gastroenterol Hepatol ; 13(1): 210, 2015 Jan.
Article in En | MEDLINE | ID: mdl-24954114
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Antibodies, Monoclonal, Humanized / Immunologic Factors / Antibodies, Monoclonal Limits: Female / Humans / Male Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2015 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Antibodies, Monoclonal, Humanized / Immunologic Factors / Antibodies, Monoclonal Limits: Female / Humans / Male Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2015 Document type: Article Affiliation country: United kingdom